Patents Represented by Attorney Patrick S. Eagleman
  • Patent number: 6974792
    Abstract: A native, chromatographically purified ?1-AT preparation having a purity of at least 0.7 PU/mg protein and a relative plasma ?1-AT activity of at least 120% is disclosed. The ratio of active to inactive ?1-AT is higher than in plasma. Furthermore, a method of producing this preparation is disclosed, as well as the use of a carrier material, e.g. an inorganic carrier material such as hydroxylapatite for separating active ?1-AT from inactive ?1-AT.
    Type: Grant
    Filed: September 24, 2001
    Date of Patent: December 13, 2005
    Assignee: Baxter Aktiengesellschaft
    Inventors: Erwin Mattes, H. Peter Matthiessen